Associations - KIT exon 11 mutation

KIT exon 11 mutation KIT exon 11 mutation	Melanoma Melanoma	KIT exon 11 mutation KIT exon 11 mutation	Melanoma Melanoma	sunitinib Sensitive: A2 - Guideline	sunitinib Sensitive: A2 - Guideline
KIT exon 11 mutation KIT exon 11 mutation	Melanoma Melanoma	KIT exon 11 mutation KIT exon 11 mutation	Melanoma Melanoma	nilotinib Sensitive: A2 - Guideline	nilotinib Sensitive: A2 - Guideline
KIT exon 11 mutation KIT exon 11 mutation	Gastric Cancer Gastric Cancer	KIT exon 11 mutation KIT exon 11 mutation	Gastric Cancer Gastric Cancer	imatinib Sensitive: B - Late Trials	imatinib Sensitive: B - Late Trials
KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	ripretinib Sensitive: B - Late Trials	ripretinib Sensitive: B - Late Trials
KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	regorafenib Sensitive: B - Late Trials	regorafenib Sensitive: B - Late Trials
KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	imatinib Sensitive: C2 – Inclusion Criteria	imatinib Sensitive: C2 – Inclusion Criteria
KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	ponatinib Sensitive: C2 – Inclusion Criteria	ponatinib Sensitive: C2 – Inclusion Criteria
KIT exon 11 mutation KIT exon 11 mutation	Melanoma Melanoma	KIT exon 11 mutation KIT exon 11 mutation	Melanoma Melanoma	imatinib Sensitive: C3 – Early Trials	imatinib Sensitive: C3 – Early Trials
KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	nilotinib Sensitive: C3 – Early Trials	nilotinib Sensitive: C3 – Early Trials
KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	sunitinib Sensitive: C3 – Early Trials	sunitinib Sensitive: C3 – Early Trials
KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	KIT exon 11 mutation KIT exon 11 mutation	Gastrointestinal Stromal Tumor GIST	avapritinib Resistant: C4 – Case Studies	avapritinib Resistant: C4 – Case Studies
KIT exon 11 mutation KIT exon 11 mutation	Melanoma Melanoma	KIT exon 11 mutation KIT exon 11 mutation	Melanoma Melanoma	dasatinib Resistant: C4 – Case Studies	dasatinib Resistant: C4 – Case Studies